Diagnosis and management of lentigo maligna: a review
- PMID: 26082796
- PMCID: PMC4453766
- DOI: 10.7573/dic.212281
Diagnosis and management of lentigo maligna: a review
Abstract
Lentigo maligna is a melanocytic neoplasm occurring on sun-exposed skin, usually on the head and neck, of middle-aged and elderly patients. It is thought to represent the in situ phase of lentigo maligna melanoma. The ill-defined nature and potentially large size of lesions can pose significant diagnostic and treatment challenges. The goal of therapy is to cure the lesions in order to prevent development of invasive disease, and surgical excision is the treatment of choice to achieve clear histological margins. Nonsurgical treatment modalities have been reported; however, evidence is lacking to support their use. Age, general health, and comorbidities need to be taken into account when deciding the right treatment modality for each individual patient.
Keywords: Mohs micrographic surgery; diagnosis; histopathology; imiquimod; immunohistochemistry; lentigo maligna; staged excision.
Figures
















Similar articles
-
Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.Acta Dermatovenerol Croat. 2018 Apr;26(1):64-67. Acta Dermatovenerol Croat. 2018. PMID: 29782304 Review.
-
Lentigo maligna : prognosis and treatment options.Am J Clin Dermatol. 2005;6(3):151-64. doi: 10.2165/00128071-200506030-00002. Am J Clin Dermatol. 2005. PMID: 15943492 Review.
-
Staged Excision for Lentigo Maligna and Lentigo Maligna Melanoma: Analysis of Surgical Margins and Long-term Recurrence in 68 Cases from a Single Practice.J Clin Aesthet Dermatol. 2016 Jun;9(6):25-30. Epub 2016 Jun 1. J Clin Aesthet Dermatol. 2016. PMID: 27386048 Free PMC article.
-
Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.Int J Dermatol. 2010 May;49(5):482-91. doi: 10.1111/j.1365-4632.2010.04423.x. Int J Dermatol. 2010. PMID: 20534080 Review.
-
[Micrographic surgery of lentigo maligna].Ned Tijdschr Geneeskd. 2016;160:A9827. Ned Tijdschr Geneeskd. 2016. PMID: 27050497 Dutch.
Cited by
-
Diagnosis and Management of Lentigo Maligna: Clinical Presentation and Comprehensive Review.J Skin Cancer. 2021 Jul 24;2021:7178305. doi: 10.1155/2021/7178305. eCollection 2021. J Skin Cancer. 2021. PMID: 34350036 Free PMC article. Review.
-
Super-High Magnification Dermoscopy Can Help for the Diagnosis of Lentigo Maligna: a Pilot Study on 61 Cases.Dermatol Pract Concept. 2023 Apr 1;13(2):e2023101. doi: 10.5826/dpc.1302a101. Online ahead of print. Dermatol Pract Concept. 2023. PMID: 37196274 Free PMC article.
-
High-frequency ultrasound for diagnosing skin cancer in adults.Cochrane Database Syst Rev. 2018 Dec 4;12(12):CD013188. doi: 10.1002/14651858.CD013188. Cochrane Database Syst Rev. 2018. PMID: 30521683 Free PMC article.
-
Melanoma: clinical, evolutive and histopathological characteristics of a series of 136 cases.An Bras Dermatol. 2018 Jun;93(3):373-376. doi: 10.1590/abd1806-4841.20186690. An Bras Dermatol. 2018. PMID: 29924223 Free PMC article.
-
Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults.Cochrane Database Syst Rev. 2018 Dec 4;12(12):CD011902. doi: 10.1002/14651858.CD011902.pub2. Cochrane Database Syst Rev. 2018. PMID: 30521682 Free PMC article.
References
-
- van Ruth S, Toonstra J. Eponyms of Sir Jonathan Hutchinson. Int J Dermatol. 2008;47(7):754–8. http://dx.doi.org/10.1111/j.1365-4632.2008.03696.x. - DOI - PubMed
-
- Gaudy-Marqueste C, Madjlessi N, Guillot B, Avril MF, Grob JJ. Risk factors in elderly people for lentigo maligna compared with other melanomas: a double case-control study. Arch Dermatol. 2009;145(4):418–23. http://dx.doi.org/10.1001/archdermatol.2009.1. - DOI - PubMed
-
- Purdue MP, From L, Kahn HJ, Armstrong BK, Kricker A, Gallagher RP, McLaughlin JR, Klar NS, Marrett LD. Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma. Int J Cancer. 2005;117(3):486–93. http://dx.doi.org/10.1002/ijc.21196. - DOI - PubMed
-
- Sasaki Y, Niu C, Makino R, Kudo C, Sun C, Watanabe H, Matsunaga J, Takahashi K, Tagami H, Aiba S, Horii A. BRAF point mutations in primary melanoma show different prevalences by subtype. J Invest Dermatol. 2004;123(1):177–83. http://dx.doi.org/10.1111/j.0022-202X.2004.22722.x. - DOI - PubMed
-
- Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;95(24):1878–90. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources